The Cognitive Stack — How Biohackers Combine Peptides for Mental Clarity

The biohacking world has a well-worn hierarchy for cognitive enhancement. Nootropics, then racetams, then hormesis protocols. Somewhere above all of it — talked about in whispers on r/Peptides and r/nootropics, debated in Longecity threads that stretch for dozens of pages — sits cognitive peptide stacking.

The appeal is obvious. Semax boosts BDNF. Selank quiets anxiety without sedation. Dihexa appears to dramatically enhance memory formation. Epithalon protects neurons and resets circadian function. On paper, they cover every dimension of cognitive performance: focus, memory, calm, and long-term neuroprotection.

But the research is patchy, the sourcing is murky, and the protocols circulating online range from brilliant to reckless. This article breaks down what the evidence actually supports, what the community is actually doing, and how to build a cognitive stack that doesn't outrun the science.

The Four Pillars of Cognitive Peptide Stacking

Before getting into combinations, each peptide deserves individual scrutiny. What does it do? How confident can we actually be?

Semax — The Focus Driver

Semax is a synthetic analog of ACTH(4-7), the adrenocorticotropic hormone fragment responsible for cognitive effects without the cortisol response. It was developed in Russia in the 1980s originally for stroke recovery and cognitive decline. It has since crossed into broader nootropic use.

Primary mechanism: Semax strongly upregulates BDNF (brain-derived neurotrophic factor) and NGF (nerve growth factor). BDNF is the key molecule behind synaptic plasticity — the brain's ability to form new connections and consolidate learning. Higher BDNF is associated with better working memory, faster learning, and protection against neurodegeneration.

Semax also modulates the dopamine and serotonin systems and appears to increase acetylcholine activity in the prefrontal cortex — the cognitive control center responsible for focus, decision-making, and working memory.

Administration: Most commonly intranasal (nasal spray). Bioavailability through the nasal mucosa is high, onset is fast (20–30 minutes). Subcutaneous injection is used less commonly in the biohacking community but is reported to be cleaner for some users.

Typical dosing: 100–300 mcg per dose, 1–2 times daily. The N-acetyl variant (NA-Semax) is more lipid-soluble and reported to cross the blood-brain barrier more efficiently; some users find it notably more potent at equivalent doses.

Full Semax profile →

Selank — The Anxiety Anchor

Selank is a heptapeptide developed by the Institute of Molecular Genetics in Moscow. It's a synthetic analog of tuftsin (an immunomodulatory peptide) with a modification that extends its half-life and enhances CNS penetration.

Primary mechanism: Selank modulates the enkephalin system — specifically, it slows the enzymatic breakdown of enkephalins, the endogenous opioid peptides responsible for mood regulation and stress response. The result is anxiolytic (anti-anxiety) effect without sedation, without tolerance, and without the withdrawal profile of benzodiazepines.

It also has documented effects on GABA-A receptor modulation — similar in direction to benzodiazepines but much weaker in magnitude — and some evidence of serotonin system support.

Why it pairs with Semax: Semax can be mildly stimulating. In some users, it produces a restless edge, especially at higher doses. Selank counteracts this. Together, they produce a state that experienced users describe as: focused without jitteriness, calm without sedation. The biohacking community calls this combination the "Russian duo" for a reason — these two were developed in the same research ecosystem and appear to work in complementary directions.

Typical dosing: 300–900 mcg per dose, 1–2 times daily, intranasal. Lower doses (300 mcg) are appropriate for daytime use when you need to stay functional; higher doses are reported to lean more sedating.

Full Selank profile →

Dihexa — The Memory Amplifier

Dihexa (PNB-0408) is a compound derived from angiotensin IV research at Washington State University. It's a hexapeptide — much smaller than most peptides — that crosses the blood-brain barrier with unusual efficiency.

Primary mechanism: Dihexa works primarily through the HGF/c-Met signaling pathway. HGF (hepatocyte growth factor) and its receptor c-Met are expressed throughout the brain and are critical for synaptogenesis — the formation of new synaptic connections between neurons. Dihexa appears to potentiate HGF/c-Met signaling dramatically, resulting in what the WSU researchers described as a 10-million-fold increase in potency compared to BDNF in driving synaptogenesis in animal models.

That's a staggering figure, which is why Dihexa generated substantial excitement in research circles. The preclinical evidence — primarily in rodent models of cognitive impairment — showed dramatic improvements in spatial memory tasks.

The honest caveat: Dihexa is the newest and least understood of these peptides. It has no human clinical trial data. The animal data is promising but cannot be directly translated to human dosing or effects. The mechanisms are real; the magnitude and safety profile in humans remain genuinely unknown.

The biohacking community has been using it anyway — cautiously — but anyone who tells you Dihexa is "proven" is overselling the evidence significantly.

Typical dosing in community use: 10–20 mg orally, or 1–5 mg subcutaneously. Oral bioavailability appears reasonable due to the molecule's lipophilicity. Effects, when reported, are described as a notable improvement in word recall, association speed, and general cognitive fluency — sometimes appearing gradually over days to weeks rather than acutely.

Epithalon — The Neuroprotector

Epithalon (Epitalon) is a synthetic tetrapeptide (Ala-Glu-Asp-Gly) developed by the St. Petersburg Institute of Bioregulation and Gerontology under Vladimir Khavinson — the same research group that developed Thymalin and Vilon.

Primary mechanism: Epithalon's most studied effect is on telomerase — the enzyme responsible for maintaining telomere length. Telomere shortening is one of the hallmarks of cellular aging, and restoration of telomerase activity in aged cells has been associated with cellular rejuvenation in in vitro studies.

In the context of cognitive health, Epithalon appears to have neuroprotective effects via antioxidant gene upregulation, circadian rhythm normalization (via melatonin regulation through the pineal gland), and protection against lipid peroxidation in neuronal tissue.

It's less of an acute cognitive enhancer and more of a long-horizon protective agent. You won't notice Epithalon working the way you'll notice Semax. You run it for its potential long-term effects on cellular aging and neural integrity.

Typical dosing: 5–10 mg daily subcutaneously for 2–4 week cycles, with 2–4 weeks off. Some protocols use lower doses (1–3 mg) and run them for longer. The Russian clinical literature used 10 mg/day intramuscularly in aging populations.

Full Epithalon profile →

Evidence Tiers: What Can You Actually Trust?

The cognitive peptide space is rife with overclaiming. This table honestly categorizes the evidence for each peptide.

Grade key: A = strong human RCT evidence. B = multiple lines of converging evidence including some human data. C = primarily preclinical or small human studies. D = anecdotal only.

The Morning/Evening Protocol: Semax + Selank

This is the most commonly discussed cognitive peptide stack, and also the most straightforward. The asymmetry is intentional: Semax in the morning for focus and cognitive drive; Selank in the evening for cortisol regulation and wind-down.

Why This Split Works

Semax's BDNF-upregulating effects align with morning tasks: deep work, learning, problem-solving. Its mild stimulant character — not caffeine-like, but a sharper, cleaner focus in most users — suits the first half of the day.

Selank's anxiolytic properties are useful throughout the day, but its stronger applications are stress buffering and transition into calm. Taking it late afternoon or early evening helps modulate cortisol (which naturally declines in healthy individuals after 4–5 PM but is often elevated in chronically stressed individuals) and supports a smoother transition to rest.

Some users run both together in the morning (the "Russian duo" approach). This tends to produce a profile that's focused but not wired — effective for high-stakes cognitive work where anxiety would otherwise intrude. But the morning/evening split gives more flexibility and is generally better tolerated.

Standard Morning/Evening Protocol

Cycle length: Most users run this protocol for 2–4 weeks continuously, then take 1–2 weeks off. Some extend to 6 weeks without issue. The primary reason to cycle off is to prevent receptor habituation — the gradual dulling of response seen with any neuroactive compound used continuously.

Start lower: First-time users should start at half the doses listed and assess response before escalating. Semax at 300 mcg is notably more stimulating than 100 mcg — don't lead with the high end.

Adding Dihexa: The Memory Layer

Dihexa is the most serious compound in the cognitive stacking toolkit, and the one that deserves the most caution. If Semax and Selank are daily drivers, Dihexa is more of a specialized tool — run periodically, not continuously.

The animal studies showing dramatic memory improvement used it at doses that were genuinely impressive. The biohacking community's experience is more mixed: some users report pronounced improvements in verbal fluency, recall, and learning speed; others report very little; a minority report feeling "mentally overloaded" — too many connections, associative noise, difficulty filtering information.

The last category is worth taking seriously. A compound that dramatically upregulates synaptogenesis via HGF/c-Met is, by definition, increasing neural connectivity. Too much connectivity can theoretically produce cognitive disorganization rather than clarity. The therapeutic window matters here, and in the absence of human clinical data, that window is estimated rather than known.

Dihexa Stacking Considerations

• Don't start Dihexa and Semax simultaneously. If you're adding Dihexa to a protocol, establish a stable Semax baseline first. This lets you isolate any unusual effects from Dihexa.
• Lower is probably better. Community reports suggest 5–10 mg oral is the effective range for most users, with 20 mg reserved for those who have clear tolerance established. Some users feel strong effects at 2–3 mg subcutaneously.
• Run in cycles, not continuously. Given the potency and unknown long-term safety, most community protocols run Dihexa for 2–4 weeks on, then at minimum an equal period off.
• Monitor subjective cognition carefully. If you notice associative thinking becoming disorganized, word retrieval becoming harder (paradoxically), or a sense of mental "too much," that's a signal to reduce dose or pause entirely.

Adding Epithalon: The Long-Game Layer

Epithalon slots into a cognitive protocol differently from Semax, Selank, or Dihexa. It's not producing acute effects on memory or focus. It's doing long-horizon work: telomere maintenance, circadian rhythm normalization, neuroprotection against oxidative damage.

The most compelling reason to include Epithalon in a cognitive stack is the circadian connection. Sleep quality is one of the most powerful determinants of cognitive function. The glymphatic system — the brain's waste-clearance mechanism — is predominantly active during slow-wave sleep. Inadequate sleep is associated with amyloid accumulation, the hallmark of Alzheimer's pathology. Anything that robustly improves sleep architecture is, indirectly, a cognitive enhancer of real consequence.

Epithalon's documented effects on melatonin synthesis through the pineal gland may represent its most practically significant benefit for younger users — not the anti-aging longevity claims, but the sleep quality improvement that shows up within one to two weeks of a cycle.

Epithalon Dosing in a Cognitive Stack

Standard cycle: 5–10 mg/day subcutaneously for 10–20 days. Rest for 2–4 months. Repeat 1–2 times per year.

Epithalon can be run concurrently with Semax and Selank without documented conflicts. The mechanisms are independent — there's no known competition at shared receptors.

The Full Cognitive Stack: How It Fits Together

The practical stack most people land on: Semax + Selank as the daily core, with periodic Dihexa cycles (2–4 weeks on when doing intensive learning or high-demand cognitive work) and Epithalon cycles 1–2 times per year for maintenance and sleep optimization.

Running all four simultaneously is not recommended as a starting point — and even experienced users typically cycle Dihexa and Epithalon rather than running them continuously.

What the Biohacking Community Is Actually Doing

The gap between published research and community practice is wide in peptide stacking. Here's an honest summary of what appears in r/Peptides, r/nootropics, and Longecity as of recent community activity:

On Semax + Selank

This is the most widely discussed cognitive stack and has the longest community track record. The dominant community consensus: it works, the effects are real but modest for most users, and the tolerability is excellent. The most common complaint is inconsistency — some batches appear more potent than others, which almost certainly reflects sourcing quality.

The N-Acetyl variants of both (NA-Semax Amidate, NA-Selank Amidate) are consistently reported as more potent than the base compounds. The additional acetyl group improves blood-brain barrier penetration. Community dosing for the amidated versions is typically 50–100% lower than for base compounds.

On Dihexa

Community sentiment is more mixed. Early adopters (circa 2015–2018) reported striking effects. More recent threads are more cautious: users note that Dihexa seems to produce strong effects in some people and little in others, with no reliable predictor. There's genuine concern in some threads about overstimulation — users describing a week or two of unusual thought patterns after starting, which resolved on cessation.

The dosing debate is ongoing: some argue that oral use requires 20 mg+ to achieve meaningful CNS exposure; others report strong effects at 5–10 mg oral. The subcutaneous route produces more consistent reports at lower doses (1–3 mg) but is logistically more demanding.

On Epithalon

Epithalon's reputation in the community is solidly positive but subdued. Users who run it primarily report better sleep and a general sense of cellular wellness — hard to quantify, but consistently reported. Cognitive benefit reports are usually indirect (better cognition via better sleep) rather than direct memory or focus improvement.

The injection logistics are the main barrier. A 10–20 day subcutaneous cycle isn't burdensome, but it's a step beyond nasal peptides. Some users use nasal Epithalon, though the community consensus is that subcutaneous provides more reliable delivery.

What's Getting Less Attention (But Probably Shouldn't)

The biohacking community tends to chase novelty. Semax and Selank have been around long enough to seem "established," and interest in Dihexa has stabilized. What's underappreciated: the evidence base for Semax's neuroprotective effects in the context of actual neurological injury or high cognitive load is arguably more interesting than its use as a general nootropic. The stroke recovery literature is real, and what works in brain injury recovery likely works — in attenuated form — in healthy optimization.

Risks and Interactions

Semax Risks

• Stimulant edge: At doses above 200–300 mcg, Semax can produce restlessness, difficulty winding down, or a keyed-up sensation. Sensitive users may experience this even at lower doses.
• BDNF concerns in predisposition to cancer: BDNF is a growth factor. There is theoretical concern that sustained BDNF upregulation could be problematic in individuals with cancer history or active tumor growth. This is theoretical, not demonstrated in the Semax literature, but worth noting.
• Interaction with MAOIs: Semax modulates monoamine systems. Combination with MAO inhibitors is contraindicated — potentially dangerous.

Selank Risks

• Mild sedation at high doses: The GABA-A component of Selank's action can produce sedation at the upper end of the dose range (750–900 mcg). Fine for evening use; avoid if driving or operating machinery.
• Potential interaction with benzodiazepines: Selank and benzodiazepines both act at GABA-A receptors via different mechanisms. Combining them could theoretically produce additive CNS depression. Do not combine without medical guidance.

Dihexa Risks

• Unknown long-term safety: There are no long-term human safety studies. The potency of its mechanism means the risk-reward calculation carries more uncertainty than with Semax or Selank.
• Cognitive disorganization at high doses: Some users report a few days of mental "noise" when starting, particularly at higher doses. This appears to resolve, but the pattern should be monitored.
• No established interactions data: Combining Dihexa with other nootropics, medications, or supplements lacks any formal study. Proceed incrementally.

Epithalon Risks

• Telomerase and cancer biology: The same concern that applies to any telomerase-activating compound: some cancers involve dysregulated telomerase. The existing clinical literature on Epithalon does not show elevated cancer rates, but the theoretical concern merits caution for those with personal or family cancer history. Discuss with an oncologist before use.
• Injection site reactions: Subcutaneous injection carries risk of local irritation, bruising, or infection if technique is poor. Standard sterile injection protocol applies.

Who Should NOT Stack These Peptides

This is not a small category. Cognitive peptide stacking is not appropriate for everyone.

• People taking MAO inhibitors (MAOIs): Contraindicated with Semax. Period.
• People taking benzodiazepines, Z-drugs, or other GABAergic medications: Selank adds GABAergic activity. Combining these creates CNS depression risk.
• People with active cancer or significant cancer history: Semax (via BDNF) and Epithalon (via telomerase) both interact with growth and cellular longevity mechanisms. Neither should be used without oncological clearance.
• People with SSRI/SNRI prescriptions: Semax and Selank both modulate serotonin to varying degrees. Interactions are not well-characterized. Discuss with your prescriber before combining with any psychiatric medication.
• People with schizophrenia or active psychosis: Compounds that modify dopamine, BDNF, or monoamine systems in already-dysregulated neurochemistry carry unpredictable risk.
• Pregnant or breastfeeding individuals: No safety data exists for any of these peptides in pregnancy or lactation. Avoid.
• People under 21: Neurological development is ongoing through early adulthood. BDNF manipulation and synaptogenesis enhancement via external compounds in still-developing brains carries meaningful unknown risk.

Dosing Schedules at a Glance

FAQ

Can I take Semax and Selank at the same time (same dose)?
Yes — the "Russian duo" approach is well-established. Combined morning dosing (Semax 100–200 mcg + Selank 300–500 mcg) is one of the most popular cognitive stacks. Semax provides the cognitive drive; Selank prevents the Semax-induced edge from becoming anxiety. Start at the low end of both doses to assess combined effect before escalating.

How long before I notice effects from Semax?
Onset is typically within 30–60 minutes of intranasal administration. Subjective focus and mental clarity are the first effects most users notice. BDNF effects are longer-term — the acute "smart drug" experience is likely not the BDNF mechanism; it's the dopaminergic/cholinergic component. The cumulative benefit from consistent BDNF upregulation builds over weeks.

Is Dihexa safe to combine with Semax?
No documented interactions, but this combination hasn't been formally studied. Both operate on different molecular targets (Semax → BDNF/neurotransmitters; Dihexa → HGF/c-Met synaptogenesis). Anecdotally, users who combine them report enhanced cognitive effects, but the combination should be approached cautiously — introduce one at a time and establish a baseline before combining.

Does Epithalon improve cognitive function directly?
Not in the way Semax does. Epithalon's cognitive benefits appear to be primarily indirect: better sleep quality via melatonin/pineal regulation, and reduced oxidative stress in neuronal tissue over time. If you're looking for acute cognitive enhancement, Epithalon won't deliver that. If you're looking for long-term brain health maintenance, it's worth considering.

Can women use these peptides?
Yes — there's nothing in the mechanism of Semax, Selank, or Epithalon that makes them sex-specific. Dihexa has no documented sex differences either. Standard cautions apply: avoid during pregnancy or breastfeeding, and discuss with a provider if you're on hormonal medications, as interaction data doesn't exist for most combinations.

What's the best entry point for someone new to cognitive peptides?
Semax alone, intranasal, at 100 mcg in the morning for one to two weeks. Assess your individual response — some people are sensitive and find 100 mcg plenty; others feel little and move to 200–300 mcg. Add Selank only after you've established a baseline Semax response. Don't start Dihexa until you've been using the Semax/Selank stack for at least a month and understand how you respond.

Are these peptides legal?
In the United States, Semax, Selank, Dihexa, and Epithalon are not approved by the FDA for human use and are not scheduled controlled substances. They exist in a legal gray zone, sold for research purposes. They cannot be marketed as dietary supplements or for human therapeutic use. Laws vary by country — Semax and Selank have approved clinical status in Russia. Check the regulations in your specific jurisdiction before purchasing or importing.

Cross-Stack Reading

Cognitive peptides don't exist in isolation. Related reading that provides important context:

• The Complete Guide to Peptide Stacking — full compatibility matrix for all major peptide categories
• Semax: Complete Profile — full mechanism, research review, and dosing guide
• Selank: Complete Profile — anxiolytic mechanisms, clinical evidence, and community usage patterns
• Epithalon: Complete Profile — telomerase, longevity, and the Khavinson research archive

The Bottom Line

Cognitive peptide stacking sits in a genuinely interesting space: not fringe pseudoscience, but not mainstream clinical practice either. The mechanisms are real. The Russian clinical data for Semax and Selank is genuine, if not as well-replicated in Western settings as we'd like. Dihexa is the wild card — promising animal data, no human trials, and a potency that demands respect. Epithalon is the patient investor of the group: slow, structural, long-horizon.

Build from the bottom up. Start with Semax alone. Add Selank. Learn your own response. Consider Epithalon if sleep quality is a limiting factor. Consider Dihexa carefully and cyclically if you've established a stable baseline and have a specific cognitive performance goal.

Don't run what Reddit recommends without understanding why. The biohacking community gets a lot right and a lot wrong — often in the same thread.

---

Affiliate Disclosure: This article may contain affiliate links. If you purchase through one of these links, WellSourced may earn a commission at no additional cost to you. We only reference products or vendors consistent with our editorial standards. Our editorial content is independent of affiliate relationships. View our full affiliate disclosure.

Medical Disclaimer: This article is for educational and informational purposes only. It does not constitute medical advice, diagnosis, or treatment. Semax, Selank, Dihexa, and Epithalon are not approved by the FDA for human therapeutic use and are sold for research purposes only. Never use peptides or any experimental compounds without consulting a qualified healthcare provider, particularly if you have a medical condition, are taking prescription medications, or are pregnant or breastfeeding. Individual responses to these compounds vary significantly. WellSourced is not responsible for any health outcomes resulting from information presented in this article.